Skip to content

menu

Health Law Pulse logo
HomeAboutContact
Search
Close
RegulatoryEnforcementFDA & Food SafetyTransparencyInternational
View topics Archives
Subscribe

Health Law Pulse

Leading insight on legal developments in the healthcare and life sciences industries.

Therapeutic Products Directorate

Subscribe to Therapeutic Products Directorate via RSS

Court upholds Health Canada decision requiring additional information ‎on certain Apotex drugs manufactured in India

Photo of Ian Trimble (CA)Photo of Kristin WallPhoto of Sara Zborovski (CA)
By Ian Trimble (CA), Kristin Wall & Sara Zborovski (CA) on April 6, 2017

The Federal Court dismissed Apotex’s application for judicial review of the Minister of Health’s decision to require additional information from Apotex as part of its submissions for certain drugs manufactured in India by Apotex affiliates.

Read the full update here

Health Law Pulse

Facebook Twitter RSS LinkedIn YouTube
Published by
Norton Rose Fulbright LLP logo
DisclaimerPrivacy policy

About

Stay up-to-date on healthcare enforcement and regulations with the Health Law Pulse. We give you the news and analysis that matter to your business in a quick, easy-to-read format.

Read more

Topics

Archives

Copyright © 2025, Norton Rose Fulbright LLP. All rights reserved.